Stockreport

Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug [CNBC]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF CNBC's Angelica Peebles joins ‘Fast Money' to report on Bristol Myers Squibb's stock rise following FDA approval of Cobenfy for treating schizophrenia in adults. [Read more]